American International Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-908
Closed -$33K 3202
2023
Q1
$33K Buy
908
+18
+2% +$1.1K ﹤0.01% 2814
2022
Q4
$53.7K Buy
890
+8
+0.9% +$536 ﹤0.01% 2726
2022
Q3
$66K Buy
882
+12
+1% +$1.25K ﹤0.01% 2732
2022
Q2
$100K Buy
870
+90
+12% +$10.6K ﹤0.01% 2600
2022
Q1
$148K Buy
780
+567
+266% +$131K ﹤0.01% 2422
2021
Q4
$74K Sell
213
-3
-1% -$1.16K ﹤0.01% 2840
2021
Q3
$73K Buy
+216
New +$111K ﹤0.01% 2909

Other funds holding OMIC

American International Group's OMIC Position: Q2 2023 in Review

American International Group sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 908 shares — an estimated $33K sold.

American International Group first reported a position in OMIC in Q3 2021 and held it in 7 quarters. The position peaked at $148K in Q1 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • American International Group reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 908 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $33K.
  • American International Group first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • American International Group's Singular Genomics Systems, Inc. Common Stock position peaked at $148K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.